Radical Addition to b-Nitrostyrenes
2123 2128
68.16, 79.11, 107.77, 111.24, 118.59, 129.42, 141.91, 152.69; MS: m/z (%): 164
(100) [M] , 107 (36), 94 (93), 42 (63).
6.6 Hz, 1H), 6.39 (d, J 16 Hz, 1H), 7.17 7.38 (m, 5H); 13C NMR
(50 MHz, CDCl3): d 32.55, 38.30, 67.70, 126.05, 127.13, 128.30, 128.56,
Compound (4h): 1H NMR (200 MHz, CDCl3): d 1.62 1.78 (m, 1H),
1.85 2.19 (m, 3H), 3.77 4.01 (m, 2H), 4.39 4.49 (m, 1H), 6.05 (dd, J
15.6, 6.6 Hz, 1H), 6.71 (d, J 15.6 Hz, 1H), 6.92 7.01 (m, 2H), 7.12 7.15
(m, 1H); 13C NMR (50 MHz, CDCl3): d 25.79, 32.27, 68.16, 79.26, 123.56,
134.64, 137.57; MS: m/z (%): 188 (100) [M] , 143 (37), 91 (52); HRMS:
calcd for C13H16O: 188.1201; found: 188.1198 [M] .
Compound (8b): 1H NMR (200 MHz, CDCl3): d 1.45 1.74 (m, 4H),
2.29 2.45 (m, 1H), 3.40 3.61 (m, 2H), 3.98 4.04 (m, 2H), 6.13 (dd, J
15.8, 6.6 Hz, 1H), 6.34 (dd, J 15.8, 1 Hz, 1H), 7.16 7.39 (m, 4H);
13C NMR (50 MHz, CDCl3): d 32.46, 38.28, 67.65, 127.17, 127.28, 128.68,
124.17, 125.66, 127.33, 130.32, 142.12; MS: m/z (%): 180 (100) [M] , 137
(53), 123 (37), 110 (88); HRMS: calcd for C10H12OS: 180.0609; found:
180.0610 [M] .
128.84, 135.34, 136.10; MS: m/z (%): 222 (34) [M] , 139 (51), 125 (51), 83
Compound (4i): 1H NMR (200 MHz, CDCl3): d 1.63 2.09 (m, 4H),
3.67 3.78 (m, 1H), 3.88 3.99 (m, 1H), 4.24 4.35 (m, 1H), 6.06 (d, J
9 Hz, 1H), 7.17 7.41 (m, 10H); 13C NMR (50 MHz, CDCl3): d 26.33,
32.99, 68.03, 76.62, 127.36, 127.45, 127.63, 128.12, 129.78, 129.98, 139.49,
(100); HRMS: calcd for C13H15OCl: 222.0812; found: 222.0814 [M] .
Compound (8c): 1H NMR (200 MHz, CDCl3): d 1.47 1.75 (m, 4H),
2.32 2.51 (m, 1H), 3.40 3.53 (m, 2H), 3.97 4.06 (m, 2H), 6.23 (dd, J 16,
6.8 Hz, 1H), 6.55 (d, J 16 Hz, 1H), 6.96 7.25 (m, 3H), 7.40 7.50 (m, 1H);
13C NMR (50 MHz, CDCl3): d 32.44, 38.69, 67.65, 115.45, 115.89, 120.71,
120.79, 124.02, 124.08, 125.17, 125.41, 126.98, 127.05, 128.24, 128.40, 137.13,
137.20, 157.66, 162.60.
Compound (8d): 1H NMR (200 MHz, CDCl3): d 1.39 1.73 (m, 4H),
2.28 2.46 (m, 1H), 3.34 3.53 (m, 2H), 3.97 4.05 (m, 2H), 6.07 (dd, J 16,
6.6 Hz, 1H), 6.35 (d, J 16 Hz, 1H), 6.93 7.18 (m, 2H), 7.21 7.36 (m, 2H);
13C NMR (50 MHz, CDCl3): d 32.55, 38.25, 67.67, 115.17, 115.61, 127.16,
127.42, 127.58, 133.70, 133.76, 134.38, 134.41, 159.67, 164.57.
142.04, 143.74; MS: m/z (%): 250 (100) [M] , 178 (67), 173 (100), 165 (74);
HRMS: calcd for C18H18O: 250.1357; found: 250.1355 [M] .
Synthesis of styryl-tetrahydropyran [(E)-6, 7, 8]: The procedure given
above was used with the precursor of radical 5 (10 mL), and the starting
materials 1a d (1 mmol) under the specified conditions shown in Table 2.
Compound (6a): 1H NMR (200 MHz, CDCl3): d 1.39 1.92 (m, 6H),
3.47 3.60 (m, 1H), 3.93 4.11 (m, 2H), 6.21 (dd, J 15.9, 5.8 Hz, 1H), 6.59
(dd, J 15.9, 1 Hz, 1H), 7.16 7.40 (m, 5H); 13C NMR (50 MHz, CDCl3):
d 23.32, 25.76, 32.14, 68.35, 77.99, 126.42, 127.43, 128.49, 129.75, 130.86,
Synthesis of styryl-cyclohexane [(E)-10]: The procedure given above was
used with the precursor of radical 9 (10 mL), and the starting materials 1a
i (1 mmol) under the specified conditions shown in Table 3.
137.05; MS: m/z (%): 188 (83) [M] , 131 (75), 104 (100); HRMS: calcd for
C13H16O: 188.1201; found: 188.1194 [M] .
Compound (6b): 1H NMR (200 MHz, CDCl3): d 1.41 1.93 (m, 6H),
3.48 3.60 (m, 1H), 3.93 4.11 (m, 2H), 6.18 (dd, J 16, 5.6 Hz, 1H), 6.54
(dd, J 16, 1.2 Hz, 1H), 7.23 7.33 (m, 4H); 13C NMR (50 MHz, CDCl3):
d 23.34, 25.76, 32.11, 68.43, 77.82, 127.66, 128.54, 128.71, 131.57, 133.09,
Compound (10c): 1H NMR (200 MHz, CDCl3): d 1.08 1.44 (m, 5H),
1.66 2.08 (m, 5H), 2.10 2.28 (m, 1H), 6.23 (dd, J 16.2, 6.8 Hz, 1H), 6.51
(d, J 16.2 Hz, 1H), 6.94 7.20 (m, 3H), 7.39 7.47 (m, 1H); 13C NMR
(50 MHz, CDCl3): d 25.95, 26.10, 32.80, 41.48, 115.37, 115.81, 119.62,
119.71, 123.93, 124.0, 125.72, 125.96, 126.90, 126.98, 127.83, 127.99, 139.39,
135.61; MS: m/z (%): 222 (100) [M] , 187 (97), 138 (91), 131 (87); HRMS:
calcd for C13H15OCl: 222.0812; found: 222.0820 [M] .
139.46, 157.64, 162.57; MS: m/z (%): 204 (32) [M] , 122 (100), 109 (23);
Compound (6c): 1H NMR (200 MHz, CDCl3): d 1.39 1.97 (m, 6H),
3.47 3.60 (m, 1H), 3.95 4.11 (m, 2H), 6.29 (dd, J 16.2, 5.6 Hz, 1H), 6.74
(d, J 16.2 Hz, 1H), 6.95 7.26 (m, 3H), 7.40 7.49 (m, 1H); 13C NMR
(50 MHz, CDCl3): d 23.29, 25.73, 32.05, 68.35, 78.08, 115.42, 115.86,
122.21, 122.27, 123.99, 124.05, 124.66, 124.90, 127.39, 127.46, 128.60, 128.77,
133.41, 133.50, 157.87, 162.83.
Compound (6d): 1H NMR (200 MHz, CDCl3): d 1.38 1.93 (m, 6H),
3.47 3.60 (m, 1H), 3.92 4.10 (m, 2H), 6.12 (dd, J 16.2, 5.6 Hz, 1H), 6.55
(d, J 16.2 Hz, 1H), 6.92 7.04 (m, 2H), 7.28 7.38 (m, 2H); 13C NMR
(50 MHz, CDCl3): d 23.32, 25.75, 32.14, 68.38, 77.88, 115.16, 115.60,
127.83, 127.99, 128.65, 130.62, 130.65, 133.18, 133.24, 159.86, 164.76.
HRMS; calcd for C14H17F: 204.1269; found: 204.1291 [M] .
Compound (10d): 1H NMR (200 MHz, CDCl3): d 1.06 1.43 (m, 5H),
1.60 1.90 (m, 5H), 2.07 2.19 (m, 1H), 6.07 (dd, J 16, 6.8 Hz, 1H), 6.30
(d, J 16 Hz, 1H), 6.90 7.05 (m, 2H), 7.24 7.32 (m, 2H); 13C NMR
(50 MHz, CDCl3): d 25.96, 26.10, 32.90, 41.04, 115.07, 115.49, 126.16,
127.28, 127.45, 134.24, 134.31, 136.61, 136.66, 159.51, 164.39; MS: m/z (%):
204 (31) [M] , 122 (100), 109 (26); HRMS: calcd for C14H17F: 204.1314;
found: 204.1311 [M] .
Compound (10e): 1H NMR (200 MHz, CDCl3): d 1.12 1.45 (m, 5H),
1.68 1.92 (m, 5H), 2.12 2.35 (m, 1H), 6.18 (dd, J 15.8, 7.0 Hz, 1H), 7.07
(d, J 15.8 Hz, 1H), 7.36 7.56 (m, 4H), 7.69 7.73 (m, 1H), 7.79 7.84 (m,
1H), 8.09 8.14 (m, 1H); 13C NMR (50 MHz, CDCl3): d 26.01, 26.16,
32.99, 41.47, 123.47, 124.0, 124.44, 125.61, 125.69, 125.73, 127.17, 128.49,
Compound (7a): 1H NMR (200 MHz, CDCl3): d 1.36 1.82 (m, 3H),
1.93 2.01 (m, 1H), 2.38 2.56 (m, 1H), 3.20 3.46 (m, 2H), 3.89 3.96 (m,
2H), 6.05 (dd, J 16, 7.2 Hz, 1H), 6.43 (d, J 16 Hz, 1H), 7.17 7.38 (m,
5H); 13C NMR (50 MHz, CDCl3): d 25.37, 29.71, 39.87, 68.12, 72.52,
131.29, 133.70, 135.97, 140.24; MS: m/z (%): 236 (88) [M] , 179 (58), 165
(64), 154 (100); HRMS: calcd for C18H20: 236.1565; found: 236.1567 [M] .
126.08, 127.27, 128.57, 130.24, 130.86, 137.43; MS: m/z (%): 188 (32) [M] ,
Compound (10i): 1H NMR (200 MHz, CDCl3): d 1.05 1.34 (m, 5H),
1.52 1.78 (m, 5H), 2.02 2.24 (m, 1H), 5.90 (d, J 9.8 Hz, 1H), 7.12 7.42
(m, 10H); 13C NMR (50 MHz, CDCl3): d 25.52, 25.92, 33.27, 38.24, 126.73,
129 (72), 104 (100); HRMS: calcd for C13H16O: 188.1201; found: 188.1204
[M] .
Compound (7b): 1H NMR (200 MHz, CDCl3): d 1.36 1.82 (m, 3H),
1.92 2.00 (m, 1H), 2.37 2.55 (m, 1H), 3.20 3.47 (m, 2H), 3.88 3.94 (m,
2H), 6.03 (dd, J 16, 7.4 Hz, 1H), 6.38 (d, J 16 Hz, 1H), 7.13 7.47 (m,
4H); 13C NMR (50 MHz, CDCl3): d 25.29, 29.62, 39.83, 68.12, 72.39,
126.80, 127.24, 128.05, 128.16, 129.81, 135.97, 139.72, 140.66, 143.0; MS: m/z
(%): 262 (78) [M] , 205 (50), 180 (100), 165 (53); HRMS: calcd for C20H22
:
262.1722; found: 262.1725 [M] .
Synthesis of styryl-cyclopentane [(E)-12]: The procedure given above was
used with toluene and the precursor of radical 11 (3 mL, volume ratio of 11/
toluene 1:4) as co-solvent, and the starting materials 1a,b, f h (1 mmol)
under the specified conditions shown in Table 4.
127.31, 128.71, 129.09, 131.61, 132.83, 135.96; MS: m/z (%): 222 (30) [M] ,
138 (100), 129 (78); HRMS: calcd for C13H15OCl: 222.0811; found: 222.0805
[M] .
Compound (7c): 1H NMR (200 MHz, CDCl3): d 1.38 1.82 (m, 3H),
1.92 2.04 (m, 1H), 2.41 2.58 (m, 1H), 3.21 3.50 (m, 2H), 3.89 3.98 (m,
2H), 6.13 (dd, J 16, 7.2 Hz, 1H), 6.59 (d, J 16 Hz, 1H), 6.96 7.23 (m,
3H), 7.37 7.46 (m, 1H); 13C NMR (50 MHz, CDCl3): d 25.31, 29.57,
40.24, 68.11, 72.39, 115.46, 115.90, 122.62, 122.70, 124.02, 124.08, 125.04,
125.28, 127.02, 127.10, 128.37, 128.54, 133.44, 133.53, 157.64, 162.59.
Compound (12a): 1H NMR (200 MHz, CDCl3): d 1.30 1.93 (m, 8H),
2.50 2.69 (m, 1H), 6.20 (dd, J 16, 7.6 Hz, 1H), 6.37 (d, J 16 Hz, 1H),
7.13 7.37 (m, 5H); 13C NMR (50 MHz, CDCl3): d 25.16, 33.15, 43.77,
125.96, 126.75, 127.89, 128.49, 135.76, 137.99; MS: m/z (%): 172 (32) [M] ,
104 (89), 84 (75), 66 (100); HRMS: calcd for C13H16: 172.1252; found:
172.1244 [M] .
Compound (7d): 1H NMR (200 MHz, CDCl3): d 1.35 1.90 (m, 3H),
1.92 2.01 (m, 1H), 2.37 2.54 (m, 1H), 3.19 3.46 (m, 2H), 3.87 3.95 (m,
2H), 5.96 (dd, J 16, 7.6 Hz, 1H), 6.39 (d, J 16 Hz, 1H), 6.92 7.04 (m,
2H), 7.19 7.35 (m, 2H); 13C NMR (50 MHz, CDCl3): d 25.32, 29.68,
39.80, 68.11, 72.48, 115.19, 115.61, 127.45, 127.61, 129.09, 130.59, 130.63,
133.56, 133.62, 159.73, 164.63.
Compound (12b): 1H NMR (200 MHz, CDCl3): d 1.29 1.92 (m, 8H),
2.48 2.67 (m, 1H), 6.16 (dd, J 16, 7.4 Hz, 1H), 6.31 (d, J 16 Hz, 1H),
7.07 7.43 (m, 4H); 13C NMR (50 MHz, CDCl3): d 25.22, 33.15, 43.77,
126.70, 127.10, 128.53, 132.18, 136.40, 136.43; MS: m/z (%): 206 (44) [M] ,
171 (45), 138 (100), 129 (79); HRMS: calcd for C13H15Cl: 206.0862; found:
206.0854 [M] .
Compound (8a): 1H NMR (200 MHz, CDCl3): d 1.46 1.74 (m, 4H),
Compound (12 f): 1H NMR (200 MHz, CDCl3): d 1.28 1.91 (m, 8H),
2.29 2.48 (m, 1H), 3.40 3.53 (m, 2H), 3.98 4.05 (m, 2H), 6.16 (dd, J 16,
2.46 2.66 (m, 1H), 3.78 (s, 3H), 6.05 (dd, J 15.8, 7.6 Hz, 1H), 6.31 (d, J
Chem. Eur. J. 2003, 9, 2123 2128
¹ 2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2127